Correction: Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-κB pathway activation through RPS3. The gene discussed is LCN2; the disease is oral cavity squamous cell carcinoma.